Adjuvant Radiation Therapy Treatment Time Impacts Overall Survival in Gastric Cancer.

[1]  D. Fraker,et al.  Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis , 2016, Annals of surgery.

[2]  D. Fraker,et al.  Omission of adjuvant therapy after gastric cancer resection: development of a validated risk model. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  Joon-Oh Park,et al.  Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Fraker,et al.  Implications of inadequate lymph node staging in resectable gastric cancer: A contemporary analysis using the National Cancer Data Base , 2014, Cancer.

[5]  D. Penson,et al.  Trends in the use of evidence‐based therapy for resectable gastric cancer , 2014, Journal of surgical oncology.

[6]  C. Ko,et al.  Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer , 2014, Annals of surgery.

[7]  B. Corn,et al.  The impact of overall radiotherapy treatment time and delay in initiation of radiotherapy on local control and distant metastases in gastric cancer , 2014, Radiation oncology.

[8]  M. Orringer,et al.  Gastric Cancer, Version 2.2013 , 2013 .

[9]  Christopher G Willett,et al.  Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. , 2012, International journal of radiation oncology, biology, physics.

[10]  J. Ajani,et al.  Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Ko,et al.  Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Ko,et al.  The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States , 2008, Annals of Surgical Oncology.

[13]  E. Rosato,et al.  Aggressive Supportive Care Improves Outcomes in the Combined Modality Treatment of Pancreatic and Duodenal Cancer , 2007 .

[14]  A. Kiss,et al.  Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer , 2006, Cancer.

[15]  Brian O'Sullivan,et al.  Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis , 2006, The Lancet.

[16]  H. Willers,et al.  Introduction to clinical radiation biology. , 2006, Hematology/oncology clinics of North America.

[17]  W. Curran,et al.  Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. , 2005, International journal of radiation oncology, biology, physics.

[18]  Cai Grau,et al.  Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial , 2003, The Lancet.

[19]  J. Macdonald.  Adjuvant therapy for gastric cancer. , 2003, Seminars in oncology.

[20]  S. Yang,et al.  The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  A. Garden,et al.  Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.

[22]  A. Garden,et al.  Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer , 2001 .

[23]  Scott A. Hundahl,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2001, The New England journal of medicine.

[24]  P. Grigsby,et al.  Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[25]  T. Wiegel,et al.  Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  T. Pajak,et al.  Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. , 1993, International journal of radiation oncology, biology, physics.

[27]  A. Fyles,et al.  The effect of treatment duration in the local control of cervix cancer. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[29]  R. Dresser,et al.  Carcinoma of the uterine cervix , 1945 .

[30]  venlig hilsen,et al.  Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck : DAHANCA 6 and 7 randomised controlled trial , 2016 .

[31]  S. Kalnicki,et al.  Predictors of radiation therapy noncompliance in an urban academic cancer center. , 2015, International journal of radiation oncology, biology, physics.

[32]  J. M. Taylor,et al.  The hazard of accelerated tumor clonogen repopulation during radiotherapy. , 1988, Acta oncologica.

[33]  E. Hall,et al.  Radiobiology for the radiologist , 1973 .